1 available, 1 completed, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow perfluoropentane: new trials by email Literature Review of perfluoropentane trials Research Report on perfluoropentane
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose Escalation Study of NanO2 in Patients With Mild Respiratory Distress dodecafluoropentane (0.025 mL/kg), dodecafluoropentane (0.032 mL/kg), dodecafluoropentane (0.050 mL/kg) - Mild Respiratory Distress | Phase 1 | Recruiting | NuvOx LLC | 18 | 2025-03-13 | 2026-01-28 |
| The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma NVX-108 - Glioblastoma Multiforme | Phase 1 | Completed | NuvOx LLC | 11 | 2014-05-01 | 2019-02-28 |
| NuvOx Expanded Access NanO₂ - Glioblastoma, Respiratory Distress Syndrom | Available | NuvOx LLC | 2026-08-05 |
Glioblastoma (2) · Dyspnea (1) · Ischemic Stroke (1)
NuvOx LLC (3)
Australia (1) · Canada (1)
Jason Lickliter, MBBSPhDFRACP (1)